AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

CUSIP: 03152W109

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 7 signals
Share change
+757,392
Put/Call ratio
97%
SEC-reported price per share
$23.09
Number of holders
267
Value change
+$41,955,777
Number of buys
124
Open additional details 1 more signal available
Number of sells
123
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
316,644,581

Security key

03152W109

Report period

Q4 2020

Institutions

267

Top holders

10

Ownership snapshot

Top reported holders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
267
Shares
279,155,505
Rows available
267
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
241
Q4 2020 holders
267
Holder diff
26
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .